title: Prostate cancer as a paradigm of multidisciplinary approach? Highlights from the Italian young radiation oncologist meeting.
abstract: OBJECTIVE
  The diagnostic and therapeutic approach to prostate cancer has evolved rapidly in last decades. Young professionals need an update about these recent developments in order to improve the care of patients treated in their daily clinical practice.
  
  
  METHODS
  On May 18, 2013, AIRO Giovani (the young section of the Italian Association of Radiation Oncology) organized a multidisciplinary meeting involving, as speakers, several young physicians from many parts of Italy actively involved in the diagnostic and therapeutic approach to prostate cancer. The meeting was specifically addressed to young physicians (radio-oncologists, urologists, medical oncologists) and presented the state-of-the-art of the diagnostic/therapeutic approach based on the latest evidence on the issue. Highlights of the congress are summarized and presented in this report.
  
  
  RESULTS
  The large participation in the meeting (more than 120 participants were present) confirmed the interest of young radiation oncologists in improving their skills in prostate cancer management. The contributions of the speakers confirmed the need for regular updates, considering the promising results of recently published studies and the many new ongoing trials, on the diagnostic and therapeutic approaches to prostate cancer.
  
  
  CONCLUSIONS
  Multidisciplinary meetings are helpful to improve the skills of young professionals.
authors: Berardino
authors: B
authors: De Bari
authors: Alba
authors: A
authors: Fiorentino
authors: Daniela
authors: D
authors: Greto
authors: Patrizia
authors: P
authors: Ciammella
authors: Stefano
authors: S
authors: Arcangeli
authors: Barbara
authors: B
authors: Avuzzi
authors: Rolando Maria
authors: RM
authors: D'Angelillo
authors: Isacco
authors: I
authors: Desideri
authors: Margarita
authors: M
authors: Kirienko
authors: Debora
authors: D
authors: Marchiori
authors: Francesco
authors: F
authors: Massari
authors: Carla
authors: C
authors: Fundoni
authors: Pierfrancesco
authors: P
authors: Franco
authors: Andrea R
authors: AR
authors: Filippi
authors: Filippo
authors: F
authors: Alongi
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000726:Androgen Antagonists / Q000008:administration & dosage / Q000627:therapeutic use*; D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage / Q000627:therapeutic use*; D014408:Biomarkers, Tumor / Q000097:blood; D001918:Brachytherapy; D002986:Clinical Trials as Topic; D019317:Evidence-Based Medicine; D006801:Humans; D007167:Immunotherapy; D033183:Interdisciplinary Communication; D007558:Italy; D008297:Male; D008875:Middle Aged; D058990:Molecular Targeted Therapy / Q000379:methods*; D009919:Orchiectomy; D010348:Patient Care Team; D010818:Practice Patterns, Physicians'; D017430:Prostate-Specific Antigen / Q000097:blood; D011468:Prostatectomy; D011471:Prostatic Neoplasms / Q000097:blood / Q000175:diagnosis* / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D012955:Societies, Medical
chemical_list: D000726:Androgen Antagonists; D018931:Antineoplastic Agents, Hormonal; D014408:Biomarkers, Tumor; D017430:Prostate-Specific Antigen